Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib and Vinorelbine in HER2+ Metastatic Breast Cancer
NCT01128543Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2009
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by GSK. Started Apr 2009; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01128543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01128543.